Decreases in Bioavailable Testosterone Linked to Alzheimer's Disease
Monday, 26 January 2004
NEW YORK (Reuters Health) - Free testosterone levels are lower among men who later develop Alzheimer's disease (AD), new study findings suggest.
read more
|
Age Over 65 Is Not Associated with Poorer Outcomes After Laparoscopic Urological Surgery
Tuesday, 30 December 2003
BERKELEY, CA (UroToday Inc.) - Minimally invasive laparoscopic surgery purportedly eases the operative burden on patients by lessening incisional pain, decreasing narcotic use, improving post-operative respiratory function, allowing earlier mobility and resulting in shorter periods of hospitalization.
read more
|
Age Over 65 Is Not Associated with Poorer Outcomes after Laparoscopic Urological Surgery
Tuesday, 30 December 2003
BERKELEY, CA (UroToday Inc.) - Minimally invasive laparoscopic surgery purportedly eases the operative burden on patients by lessening incisional pain, decreasing narcotic use, improving post-operative respiratory function, allowing earlier mobility and resulting in shorter periods of hospitalization.
read more
|
Report Concludes That Hot Flushes Occur in Older Men as Often as They do in Women
Wednesday, 10 December 2003
?Hot flushes? announce onset of menopausal changes for most women. They accept and anticipate these symptoms.
read more
|
Report Concludes That Hot Flushes Occur in Older Men as Often as They Do in Women
Wednesday, 10 December 2003
?Hot flushes? announce onset of menopausal changes for most women. They accept and anticipate these symptoms.
read more
|
DHEA Increases Foam Cell Formation
Friday, 05 December 2003
NEW YORK (Reuters Health) - Dehydroepiandrosterone (DHEA), a supplement popular with men for its possible anti-aging effects, seems to increase macrophage foam cell formation in vitro, Australian researchers report. This means it could raise the risk of atherosclerotic disease.
read more
|
Bioavailable Testosterone Useful Marker for Diagnosis and Treatment of Partial Androgen Deficiency in the Aging Male (PADAM)
Thursday, 04 December 2003
Dr. A. Tsujimura and his associates at Osaka University, Japan, discuss in the December 2003 issue of the Journal of Urology their approach to use of bioavailable testosterone (BT) in management of PADAM in 130 patients.
read more
|
Trials Needed for Use of Testosterone as Anti-aging Drug
Wednesday, 12 November 2003
WASHINGTON (Reuters) - Older men should not take testosterone as an anti-aging agent until there has been a large-scale study of the hormone therapy's true risks and benefits, a U.S. advisory committee said on Wednesday.
read more
|
Curative Therapy Benefits Older Men with Localized Prostate Cancer
Thursday, 18 September 2003
NEW YORK (Reuters Health) - Many older men with localized prostate cancer gain life expectancy and quality-adjusted life expectancy with potentially curative therapy, according to a report in the September 1st Journal of Clinical Oncology.
read more
|
Idiopathic Hypercalciuria a Leading Cause of Osteoporotic Fractures
Friday, 20 June 2003
NEW YORK (Reuters Health) - Vertebral fractures occur significantly more often in people with than in those without hypercalciuria, results of a prospective study indicate.
read more
|
FDA Clears Columbia Labs' Buccal Testosterone Delivery Product
Friday, 20 June 2003
NEW YORK (Reuters) - Columbia Laboratories Inc. said on Friday that U.S. regulators had approved its male hormone-replacement drug Striant, the first drug to deliver testosterone through a tablet adhered to the gums.
read more
|
Androgen Suppression Can Be Discontinued in Some Prostate Cancer Patients
Wednesday, 16 April 2003
NEW YORK (Reuters Health) - Withdrawing hormonal therapy appears safe for elderly patients with advanced prostate cancer who are asymptomatic and have achieved an undetectable PSA level after prolonged androgen blockade, according to a report in the April issue of Urology.
read more
|
Estrogen and Testosterone Important for Regulating Bone Growth in Men
Wednesday, 19 February 2003
NEW YORK (Reuters Health) - Findings from a new study suggest that estrogen as well as testosterone plan a crucial role in regulating bone resorption in men.
read more
|
Institute of Medicine Panel Mulls Testosterone Replacement Questions
Thursday, 30 January 2003
WASHINGTON (Reuters Health) - Federal advisers began the first of several meetings Thursday that will result in recommendations later this year on how clinical trials can best assess the pros and cons of testosterone replacement therapy in aging men.
read more
|
New Drug Shows Promise Against Hard-to-treat Breast and Prostate Cancers
Tuesday, 13 August 2002
NEW YORK (Reuters Health) - A new monoclonal antibody against ErbB2, known as 2C4, inhibits the growth of breast tumors that express low and high levels of ErbB2 and the growth of prostate tumors that are resistant to hormone blocking drugs, animal study findings indicate.
read more
|
Geriatric Urology 
